XML 44 R24.htm IDEA: XBRL DOCUMENT v3.20.2
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS
12 Months Ended
Dec. 31, 2019
Accounting Changes and Error Corrections [Abstract]  
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS
18.RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

 

On February 14, 2020, the Company filed a Form 8-K disclosing that the Audit & Finance Committee of the Company’s Board of Directors, determined, based on the recommendation of management, that the Company’s consolidated financial statements which were included in its annual report on Form 10-K for the year ended December 31, 2018, quarterly reports on Forms 10-Q for the quarters ended March 31, 2018, June 30, 2018, and September 30, 2018 and quarterly reports on Forms 10-Q for the quarters ended March 31, 2019, June 30, 2019, and September 30, 2019 and related financial information should no longer be relied upon, and determined that the consolidated financial statements will be restated. The errors were uncovered as part of the preparation of the Company’s consolidated financial statements for the fiscal year ended December 31, 2019.

 

As a result, the Company restated the 2018 consolidated financial statements, which is referred to as the “Restatement.” The Restatement corrects errors which are discussed in detail within this footnote.

 

The errors primarily related to the timing of recognition of revenue from contracts with customers.

 

Restatement

 

The following is a discussion of the restatement adjustments that were made to the Company’s previously issued consolidated financial statements:

 

(a) Revenue recognition

 

The Company recognizes revenues and profits for contracts with customers using the cost-to-cost percentage of completion method of accounting. Historically, for long-term programs, the Company applied the cost-to-cost percentage of completion method at the program level, that is, for the entire duration of expected production activity on a particular program. The Company estimated its revenue recognition utilizing the life of the program to both measure progress and estimate profit margin. Under this approach, the Company estimated the total expected customer purchases over the life of the program, which included unexercised and non-binding customer purchase options, which resulted in the recognition of $100.9 million of misstated contract assets, contract liabilities and loss reserves.

 

The Company has now concluded that its life of the program accounting was not an appropriate application of ASC Topic 606. Under ASC Topic 606, the performance obligation is the appropriate unit of accounting. The Company identifies performance obligations to customers once a contract is established in accordance with ASC Topic 606. For the Company, the contract under ASC Topic 606 is typically established upon execution of a purchase order either in accordance with a long-term customer agreement or on a standalone basis. The transaction price is also determined at the contract level and excludes amounts related to unexercised customer options. Similarly, the Company’s cost-to-cost input method to measure progress must consider only the costs incurred relative to the total expected costs of satisfying the performance obligations identified in the contract, exclusive of unexercised customer options.

 

To correct these errors, the related revenue was reversed in the period in which the accounting errors took place and recognized in subsequent periods as control of the goods or services in the contract passed to the customer over time based on a cost-to-cost input method measure of progress. Additionally, certain adjustments to contract assets and contract liabilities were made to the consolidated balance sheet at the end of the period in which the accounting errors occurred.

 

(b) Other

 

The Company corrected other immaterial misstatements relating to previously unrecorded audit adjustments.

 

(c) Income taxes

 

The Company has recorded tax adjustments related to the impact of the restatement.

 

Impact on Consolidated Statements of Operations

 

The effect of the Restatement described above on the accompanying consolidated statements of operations for the fiscal year ended December 31, 2018 is as follows:

                     
   For the Year Ended December 31, 2018 
   As Previously
Reported
   Revenue
Recognition
   Other   Income Taxes   As Restated 
Revenue  $83,929,270   $(13,563,254)  $   $   $70,366,016 
Cost of sales   65,765,007    671,122    (280,143)       66,155,986 
Gross profit   18,164,263    (14,234,376)   280,143        4,210,030 
Selling, general and administrative expenses   9,528,883        251,144        9,780,027 
Income (loss) from operations   8,635,380    (14,234,376)   28,999        (5,569,997)
Other expense:                         
Other income   28,709                28,709 
Interest expense   (1,989,417)               (1,989,417)
Total other expense, net   (1,960,708)               (1,960,708)
Income (loss) before provision for income taxes   6,674,672    (14,234,376)   28,999        (7,530,705)
Provision for income taxes   4,463,109            (4,447,061)   16,048 
Net income (loss)   2,211,563    (14,234,376)   28,999    4,447,061    (7,546,753)
Other comprehensive income net of tax – change                       
Change in unrealized loss-interest rate swap   14,800                   14,800 
Comprehensive income (loss)  $2,226,363   $(14,234,376)  $28,999   $4,447,061   $(7,531,953)
                          
Income (loss) per common share – basic  $0.23                  $(0.80)
Income (loss) per common share – diluted  $0.23                  $(0.80)
                          
Shares used in computing earnings per common share:                         
Basic   9,480,948                   9,480,948 
Diluted   9,489,630                   9,480,948 

 

Impact on Consolidated Statement of Comprehensive Income (Loss)

 

The only change to the consolidated statement of comprehensive income (loss) for the fiscal year ended December 31, 2018 as a result of the Restatement is due to the change in net income (loss).

 

Impact on Consolidated Balance Sheet

 

The effect of the Restatement described above on the accompanying consolidated balance sheet as of December 31, 2018 is as follows:

 

   As of December 31, 2018 
   As Previously
Reported
   Revenue
Recognition
   Other   Income Taxes   As Restated 
ASSETS                    
Current Assets:                         
Cash  $4,128,142   $   $   $   $4,128,142 
Restricted cash   2,000,000                2,000,000 
Accounts receivable, net   8,623,329        99,242        8,722,571 
Contract assets   113,333,491    (95,744,625)           17,588,866 
Inventory   9,711,997        (350,386)       9,361,611 
Refundable income taxes   435,000            (97)   434,903 
Prepaid expenses and other current assets   1,972,630                1,972,630 
Total Current Assets   140,204,589    (95,744,625)   (251,144)   (97)   44,208,723 
                          
Property and equipment, net   2,545,192                2,545,192 
Refundable income taxes   435,000            (97)   434,903 
Deferred income taxes   279,318            (279,318)    
Other assets   249,575                249,575 
Total Assets  $143,713,674   $(95,744,625)  $(251,144)  $(279,512)  $47,438,393 
                          
Liabilities and Shareholders' Equity (Deficit)                         
Current Liabilities:                         
Accounts payable  $9,902,481   $   $   $   $9,902,481 
Accrued expenses   1,558,160                1,558,160 
Contract liabilities   3,588,500    1,664,079            5,252,579 
Loss reserve   216,606    3,446,952            3,663,558 
Current portion of long-term debt   2,434,981                2,434,981 
Income taxes payable   115,000            (1,008)   113,992 
Total Current Liabilities   17,815,728    5,111,031        (1,008)   22,925,751 
                          
Line of credit   24,038,685                24,038,685 
Long-term debt, net of current portion   3,876,238                3,876,238 
Deferred income taxes   4,028,553            (4,028,553)    
Other liabilities   531,124                531,124 
Total Liabilities   50,290,328    5,111,031        (4,029,561)   51,371,798 
                          
Shareholders’ Equity (Deficit):                         
Common stock   11,718                11,718 
Additional paid-in capital   70,651,413                70,651,413 
Retained earnings (accumulated deficit)   22,760,215    (100,855,656)   (251,144)   3,750,049    (74,596,536)
Total Shareholders’ Equity (Deficit)   93,423,346    (100,855,656)   (251,144)   3,750,049    (3,933,405)
Total Liabilities and Shareholders’
Equity (Deficit)
  $143,713,674   $(95,744,625)  $(251,144)  $(279,512)  $47,438,393 

 

 

Cumulative Effect of Prior Period Adjustments

 

The following table presents the impact of the Restatement on the Company’s shareholders’ equity (deficit) as of January 1, 2018:

 

  

Common

Stock

   Additional
Paid-in
Capital
   Retained
Earnings
(accumulated
deficit)
   Accumulated
Other
Comprehensive
Loss
   Total
Shareholders’
Equity
(Deficit)
 

Balance, January 1, 2018 

(As previously reported) 

  $8,864   $53,770,617   $20,548,652   $(14,800)  $74,313,333 
Adjustments:                         
Revenue recognition           (86,621,280)       (86,621,280)
Other           (280,143)       (280,143)
Income taxes           (697,012)       (697,012)
Cumulative restatement adjustments           (87,598,435)       (87,598,435)

Balance, January 1, 2018 

(As Restated)

  $8,864   $53,770,617   $(67,049,783)  $(14,800)  $(13,285,102)

 

 

Impact on Consolidated Statement of Cash Flows

 

The effect of the Restatement described above on the accompanying consolidated statement of cash flows for the fiscal year ended December 31, 2018 is as follows:

 

   For the Year Ended December 31, 2018 
   As Previously
Reported
   Restatement
Adjustments
   As Restated 
Cash flows from operating activities:               
Net income (loss)  $2,211,563   $(9,758,316)  $(7,546,753)
Adjustments to reconcile net income (loss) to net cash used in operating activities:               
Depreciation and amortization   710,197        710,197 
Amortization of debt issuance cost   95,942    (436)   95,506 
Deferred rent   (70,764)       (70,764)
Stock-based compensation expense   671,620        671,620 
Common stock issues as employee compensation   45,913        45,913 
Deferred income taxes   5,337,053    (5,337,053)    
Adjustment for maturity of interest rate swap   20,600    (5,800)   14,800 
Bad debt expense   125,000    (99,242)   25,758 
Changes in operating assets and liabilities, net of effects of acquisition:               
Increase in accounts receivable   (1,796,225)   (50,283)   (1,846,508)
(Increase) decrease in contract assets   (2,174,941)   12,629,627    10,454,686 
(Increase) decrease in inventory   (57,272)   350,038    292,766 
(Increase) decrease in prepaid expenses and other current assets   5,702    (27,957)   (22,255)
Increase in refundable income taxes   (870,000)   870,000     
Decrease in accounts payable and accrued expenses   (7,696,024)   (230,771)   (7,926,795)
Increase in contract liabilities   866,968    1,563,954    2,430,922 
Increase (decrease) in loss reserve   44,933    (59,329)   (14,396)
Decrease in other liabilities   (10,976)   5,801    (5,175)
Increase in income taxes payable   5,673    (1,008)   4,665 
Net cash used in operating activities   (2,535,038)   (150,775)   (2,685,813)
Cash flows from investing activities:               
Purchase of property and equipment   (559,037)       (559,037)
Purchase of WMI   (6,050,906)   98,906    (5,952,000)
Net cash used in investing activities   (6,609,943)   98,906    (6,511,037)
Cash flows from financing activities:               
Net proceeds from sale of common stock   16,166,117        16,166,117 
Payment of line of credit   (6,500,000)       (6,500,000)
Proceeds from line of credit   7,700,000        7,700,000 
Payment of long-term debt   (3,314,789)       (3,314,789)
Debt issuance costs   (209,082)   51,869    (157,213)
Net cash provided by financing activities   13,842,246    51,869    13,894,115 
Net increase in cash and restricted cash   4,697,265        4,697,265 
Cash and restricted cash at beginning of year   1,430,877        1,430,877 
Cash and restricted cash at end of year  $6,128,142   $   $6,128,142 
Supplemental schedule of noncash investing and financing activities:               
Equipment acquired under capital leases  $649,410   $   $649,410 
Supplemental schedule of cash flow information:               
Cash paid during the year for interest  $2,134,574   $   $2,134,574 
Cash paid for income taxes  $10,947   $   $10,947